Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Atrial Fibrillation and CES1[original query] |
---|
Genetic determinants of dabigatran plasma levels and their relation to bleeding.
Circulation 2013 Apr 127 (13): 1404-12. Paré Guillaume, Eriksson Niclas, Lehr Thorsten, Connolly Stuart, Eikelboom John, Ezekowitz Michael D, Axelsson Tomas, Haertter Sebastian, Oldgren Jonas, Reilly Paul, Siegbahn Agneta, Syvanen Ann-Christine, Wadelius Claes, Wadelius Mia, Zimdahl-Gelling Heike, Yusuf Salim, Wallentin La |
Pharmacogenetics of dabigatran etexilate interindividual variability. Thrombosis research 2016 May 144 1-5. Dimatteo Claudia, D'Andrea Giovanna, Vecchione Gennaro, Paoletti Oriana, Cappucci Filomena, Tiscia Giovanni Luca, Buono Matteo, Grandone Elvira, Testa Sophie, Margaglione Mauriz |
Left atrial appendage thrombus formation in a patient with atrial fibrillation on dabigatran therapy associated with CES1 and ABCB1 genetic polymorphisms: A case report. Medicine 2020 9 99 (36): e22084. Wu Tingting, Xia Xiaotong, Fu Jinglan, Chen Wenjun, Zhang Jinh |
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease. Drug metabolism and personalized therapy 2020 Mar . Sychev Dmitriy, Skripka Alena, Ryzhikova Kristina, Bochkov Pavel, Shevchenko Roman, Krupenin Pavel, Ivashchenko Dmitriy, Kogay Veronika, Listratov Alexander, Krainyaya Arina, Gurinovich Olga, Sokolova Anastasiya, Napalkov Dmitriy, Fomin Vikt |
The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation. British journal of clinical pharmacology 2020 Nov . Ji Qiuyi, Zhang Chunyu, Xu Qing, Wang Zi, Li Xiaoye, Lv Qianzh |
Associations among plasma concentrations of edoxaban and M-4, prothrombin time, and the SLCO1B1*15 haplotype in patients with non-valvular atrial fibrillation. Therapeutic drug monitoring 2022 Sep . Nakagawa Junichi, Kinjo Takahiko, Aiuchi Naoya, Ueno Kayo, Tomita Hirofumi, Niioka Takeno |
The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation. BMC cardiovascular disorders 2022 11 22 (1): 481. Zhu Zhu, Qian Chenyue, Su Cunjing, Tao Hong, Mao Jiaojiao, Guo Zhening, Zhu Xinyi, Pan J |
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation. Pharmacology 2022 Jan 1-11. Baturina Olga, Andreev Denis, Fedina Ludmila, Mirzaev Karin, Ivashchenko Dmitriy, Ryzhikova Kristina, Grishina Elena, Bochkov Pavel, Shevchenko Roman, Sychev Dmitr |
The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC. Genes 2023 6 14 (6): . Ayan Abdrakhmanov, Ainur Akilzhanova, Aizhan Shaimerdinova, Madina Zhalbinova, Gulnara Tuyakova, Svetlana Abildinova, Rustam Albayev, Bayan Ainabekova, Assel Chinybayeva, Zhanasyl Suleimen, Makhabbat Bekbossyno |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: